Orbital exenteration in immunodeficiency virus-infected patients

Kagmeni Giles,1,2 Yannick Bilong,1,2 Nomo Arlette,1,2 Nanfack Chantal,1,3 Bella Assumpta Lucienne1,3 1Eye Department, University of Yaoundé I, 2Yaounde Teaching Hospital, 3Gyneco-Obstetric and Pediatric Hospital, Yaoundé, Cameroon Background: Orbital exenter...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Giles K, Bilong Y, Arlette N, Chantal N, Lucienne BA
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
HIV
Acceso en línea:https://doaj.org/article/c499c18c57934be1ad08c738af84b1aa
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c499c18c57934be1ad08c738af84b1aa
record_format dspace
spelling oai:doaj.org-article:c499c18c57934be1ad08c738af84b1aa2021-12-02T00:15:20ZOrbital exenteration in immunodeficiency virus-infected patients1177-5483https://doaj.org/article/c499c18c57934be1ad08c738af84b1aa2016-10-01T00:00:00Zhttps://www.dovepress.com/orbital-exenteration-in-immunodeficiency-virus-infected-patients-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Kagmeni Giles,1,2 Yannick Bilong,1,2 Nomo Arlette,1,2 Nanfack Chantal,1,3 Bella Assumpta Lucienne1,3 1Eye Department, University of Yaoundé I, 2Yaounde Teaching Hospital, 3Gyneco-Obstetric and Pediatric Hospital, Yaoundé, Cameroon Background: Orbital exenteration (OE) is a disfiguring procedure most commonly performed for locally advanced and potentially life-threatening periorbital malignancies.Methods: We retrospectively reviewed records of 11 consecutive HIV patients who underwent OE for invasive orbital malignancy at our institution from January 2005 to December 2015. Patient demographic and clinic data and histopathology of the tumor were analyzed.Results: There were eight (72.72%) female and three (27.28%) male participants ranging in age from 31 to 52 years with an mean of 39.4 years. Nine patients had been known to be HIV-positive for at least 2 years, and HIV-positive status was revealed at presentation for two patients. The mean CD4 cell count was 154.4 cells/mm3. Histopathological examination showed invasive orbital squamous cell carcinomas in nine patients (81.81%), achromic orbital melanoma in one patient (9.09%), and adenoid cystic carcinoma in one patient (9.09%). None of the patients underwent primary orbital reconstruction. The mean follow-up time was 3.4 months. Only one patient who underwent adjuvant radiotherapy was seen after 12 months.Conclusion: Oculo-orbital malignancies are very aggressive in HIV-positive individuals, especially in untreated patients. Routine screening for suspected ocular surface lesions and early surgical removal of all these lesions could help to avoid the need to perform the radical and disfiguring OE procedure. Keywords: orbital tumors, achromic melanoma, squamous cell carcinoma, HIVGiles KBilong YArlette NChantal NLucienne BADove Medical PressarticleKeywords: orbital tumorsorbital exenterationsquamous cell carcinomaHIVOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 10, Pp 2055-2059 (2016)
institution DOAJ
collection DOAJ
language EN
topic Keywords: orbital tumors
orbital exenteration
squamous cell carcinoma
HIV
Ophthalmology
RE1-994
spellingShingle Keywords: orbital tumors
orbital exenteration
squamous cell carcinoma
HIV
Ophthalmology
RE1-994
Giles K
Bilong Y
Arlette N
Chantal N
Lucienne BA
Orbital exenteration in immunodeficiency virus-infected patients
description Kagmeni Giles,1,2 Yannick Bilong,1,2 Nomo Arlette,1,2 Nanfack Chantal,1,3 Bella Assumpta Lucienne1,3 1Eye Department, University of Yaoundé I, 2Yaounde Teaching Hospital, 3Gyneco-Obstetric and Pediatric Hospital, Yaoundé, Cameroon Background: Orbital exenteration (OE) is a disfiguring procedure most commonly performed for locally advanced and potentially life-threatening periorbital malignancies.Methods: We retrospectively reviewed records of 11 consecutive HIV patients who underwent OE for invasive orbital malignancy at our institution from January 2005 to December 2015. Patient demographic and clinic data and histopathology of the tumor were analyzed.Results: There were eight (72.72%) female and three (27.28%) male participants ranging in age from 31 to 52 years with an mean of 39.4 years. Nine patients had been known to be HIV-positive for at least 2 years, and HIV-positive status was revealed at presentation for two patients. The mean CD4 cell count was 154.4 cells/mm3. Histopathological examination showed invasive orbital squamous cell carcinomas in nine patients (81.81%), achromic orbital melanoma in one patient (9.09%), and adenoid cystic carcinoma in one patient (9.09%). None of the patients underwent primary orbital reconstruction. The mean follow-up time was 3.4 months. Only one patient who underwent adjuvant radiotherapy was seen after 12 months.Conclusion: Oculo-orbital malignancies are very aggressive in HIV-positive individuals, especially in untreated patients. Routine screening for suspected ocular surface lesions and early surgical removal of all these lesions could help to avoid the need to perform the radical and disfiguring OE procedure. Keywords: orbital tumors, achromic melanoma, squamous cell carcinoma, HIV
format article
author Giles K
Bilong Y
Arlette N
Chantal N
Lucienne BA
author_facet Giles K
Bilong Y
Arlette N
Chantal N
Lucienne BA
author_sort Giles K
title Orbital exenteration in immunodeficiency virus-infected patients
title_short Orbital exenteration in immunodeficiency virus-infected patients
title_full Orbital exenteration in immunodeficiency virus-infected patients
title_fullStr Orbital exenteration in immunodeficiency virus-infected patients
title_full_unstemmed Orbital exenteration in immunodeficiency virus-infected patients
title_sort orbital exenteration in immunodeficiency virus-infected patients
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/c499c18c57934be1ad08c738af84b1aa
work_keys_str_mv AT gilesk orbitalexenterationinimmunodeficiencyvirusinfectedpatients
AT bilongy orbitalexenterationinimmunodeficiencyvirusinfectedpatients
AT arletten orbitalexenterationinimmunodeficiencyvirusinfectedpatients
AT chantaln orbitalexenterationinimmunodeficiencyvirusinfectedpatients
AT lucienneba orbitalexenterationinimmunodeficiencyvirusinfectedpatients
_version_ 1718403889531715584